Roche Holding AG (RHHBY)

Swiss pharmaceutical giant Roche on Tuesday said that it would invest $50 billion in the United States.

The pharma giant said the investment would create more than 12,000 new jobs, as it joins rival Novartis in expanding its footprint in the country amid President Trump's tariff threats.

Roche on Tuesday said it will invest $50 billion in the United States over the next five years, in one of the biggest inward investment moves by companies dealing with President Donald Trump's tariffs...

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #biotech--Oak Hill Bio has entered into an exclusive license agreement with Roche to obtain global rights for rugonersen for Angelman syndrome.

The European Commission approves RHHBY's Columvi combo to treat adult patients with diffuse large B-cell lymphoma after initial therapy.

The Trump administration's proposed tariffs on pharmaceuticals have caused significant stock declines, but their implementation remains uncertain and may be aimed at achieving specific goals. Roche's ...

President Donald Trump's planned tariffs on pharmaceuticals imported into the U.S. could have wide-ranging consequences on the drug supply chain, manufacturers and American patients, some experts told...

The Danish biotech's recruitment drive began last summer when data from an early-stage trial of the drug—petrelintide—showed its potential.

VANCOUVER, BC / ACCESS Newswire / April 10, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its subsidiary, In...